Literature DB >> 9516483

Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors.

T Joneson1, J A Fulton, D J Volle, O V Chaika, D Bar-Sagi, R E Lewis.   

Abstract

Kinase suppressor of Ras (KSR) is a loss-of-function allele that suppresses the rough eye phenotype of activated Ras in Drosophila and the multivulval phenotype of activated Ras in Caenorhabditis elegans. Genetic and biochemical studies suggest that KSR is a positive regulator of Ras signaling that functions between Ras and Raf or in a pathway parallel to Raf. We examined the effect of mammalian KSR expression on the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase in fibroblasts. Ectopic expression of KSR inhibited the activation of ERK MAP kinase by insulin, phorbol ester, or activated alleles of Ras, Raf, and mitogen and extracellular-regulated kinase. Expression of deletion mutants of KSR demonstrated that the KSR kinase domain was necessary and sufficient for the inhibitory effect of KSR on ERK MAP kinase activity. KSR inhibited cell transformation by activated RasVal-12 but had no effect on the ability of RasVal-12 to induce membrane ruffling. These data indicate that KSR is a potent modulator of a signaling pathway essential to normal and oncogenic cell growth and development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516483     DOI: 10.1074/jbc.273.13.7743

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells.

Authors:  Robert L Kortum; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 3.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

4.  Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells.

Authors:  D Chevalier; E Thorin; B G Allen
Journal:  J Pharmacol Toxicol Methods       Date:  2000 Sep-Oct       Impact factor: 1.950

5.  IMP modulates KSR1-dependent multivalent complex formation to specify ERK1/2 pathway activation and response thresholds.

Authors:  Chiyuan Chen; Robert E Lewis; Michael A White
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

6.  ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.

Authors:  Hema Vaidyanathan; John Opoku-Ansah; Sandra Pastorino; Hema Renganathan; Michelle L Matter; Joe W Ramos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

7.  The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.

Authors:  Robert L Kortum; Heidi J Johnson; Diane L Costanzo; Deanna J Volle; Gina L Razidlo; Angela M Fusello; Andrey S Shaw; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Quantitative effect of scaffold abundance on signal propagation.

Authors:  Stephen A Chapman; Anand R Asthagiri
Journal:  Mol Syst Biol       Date:  2009-10-13       Impact factor: 11.429

9.  Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists.

Authors:  Tomas Vomastek; Hans-Joerg Schaeffer; Adel Tarcsafalvi; Mark E Smolkin; Eric A Bissonette; Michael J Weber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

10.  Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence.

Authors:  E G Ignatova; M M Belcheva; L M Bohn; M C Neuman; C J Coscia
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.